The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Use of Gastric Acid–Suppressive Agents and the Risk of Community-Acquired <EMPH TYPE="ITAL">Clostridium difficile</EMPH>–Associated Disease
Abstract
CONTEXT: Recent reports suggest an increasing occurrence and severity of Clostridium difficile-associated disease. We assessed whether the use of gastric acid-suppressive agents is associated with an increased risk in the community. OBJECTIVE: To determine whether the use of gastric acid-suppressive agents increases the risk of C difficile-associated disease in a community population. DESIGN, SETTING, AND PATIENTS: We conducted 2 population-based case-control studies using the United Kingdom General Practice Research Database (GPRD). In the first study, we identified all 1672 cases of C difficile recorded between 1994 and 2004 among all patients registered for at least 2 years in each practice. Each case was matched to 10 controls on calendar time and the general practice. In the second study, a subset of these cases defined as community-acquired, that is, not hospitalized in the prior year, were matched on practice and age with controls also not hospitalized in the prior year. MAIN OUTCOME MEASURES: The incidence of C difficile and risk associated with gastric acid-suppressive agent use. RESULTS: The incidence of C difficile in patients diagnosed by their general practitioners in the General Practice Research Database increased from less than 1 case per 100,000 in 1994 to 22 per 100,000 in 2004. The adjusted rate ratio of C difficile-associated disease with current use of proton pump inhibitors was 2.9 (95% confidence interval [CI], 2.4-3.4) and with H2-receptor antagonists the rate ratio was 2.0 (95% CI, 1.6-2.7). An elevated rate was also found with the use of nonsteroidal anti-inflammatory drugs (rate ratio, 1.3; 95% CI, 1.2-1.5). CONCLUSIONS: The use of acid-suppressive therapy, particularly proton pump inhibitors, is associated with an increased risk of community-acquired C difficile. The unexpected increase in risk with nonsteroidal anti-inflammatory drug use should be investigated further.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warny, M., Pepin, J., Fang, A., Killgore, G., Thompson, A., Brazier, J., Frost, E., & McDonald, L. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67420-x · Cited by 1,430
Pepin, J. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041104 · Cited by 1,128
BIAS DUE TO MISCLASSIFICATION IN THE ESTIMATION OF RELATIVE RISK
COPELAND, K. T., CHECKOWAY, H., McMICHAEL, A. J., & HOLBROOK, R. H. (1977) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112408 · Cited by 1,000
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive Drugs
Laheij, R. J. F. (2004) · JAMA · doi:10.1001/jama.292.16.1955 · Cited by 877
Jick, H., Jick, S. S., & Derby, L. E. (1991) · BMJ · doi:10.1136/bmj.302.6779.766 · Cited by 839
Wheeler, J. G., Sethi, D., Cowden, J. M., Wall, P. G., Rodrigues, L. C., Tompkins, D. S., Hudson, M. J., & Roderick, P. J. (1999) · BMJ · doi:10.1136/bmj.318.7190.1046 · Cited by 794 · cited 3×
“A British cohort study identified C difficile as the third most common cause of infectious diarrhea in patients aged 75 years and older seen by general practitioners.(4,5) A French prospective cohort study performed in outpatients to whom antibiotics were prescribed reported an incidence of C difficile–associated dise…”
BackgroundRisk factors for Clostridium difficile infection
Bignardi, G. E. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90019-6 · Cited by 647
The UK General Practice Research Database
Walley, T., & Mantgani, A. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04248-7 · Cited by 623
Muto, C. A., Pokrywka, M., Shutt, K., Mendelsohn, A. B., Nouri, K., Posey, K., Roberts, T., Croyle, K., Krystoflak, S., Patel-Brown, S., et al. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502539 · Cited by 619
Pepin, J. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050978 · Cited by 606
Validity of the General Practice Research Database
Jick, S. S., Kaye, J. A., Vasilakis‐Scaramozza, C., Rodríguez, L. A. G., Ruigómez, A., Meier, C. R., Schlienger, R. G., Black, C., & Jick, H. (2003) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.5.686.32205 · Cited by 584
Dial, S. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040876 · Cited by 577
Self-citationUse of the UK General Practice Research Database for pharmacoepidemiology
García Rodríguez, L. A., & Pérez Gutthann, S. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00701.x · Cited by 558
Safdar, N., & Maki, D. G. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-11-200206040-00013 · Cited by 556
Clostridium difficile–Associated Diarrhea
Johnson, S., & Gerding, D. N. (1998) · Clinical Infectious Diseases · doi:10.1086/520276 · Cited by 441
Gerding, D. N. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360130117016 · Cited by 370
(1992) · American Journal of Infection Control · doi:10.1016/s0196-6553(05)80130-0 · Cited by 363
Nosocomial Clostridium difficile colonisation and disease
Johnson, S., Clabots, C. R., Linn, F. V., Olson, M. M., Peterson, L. R., Gerding, D. N., Johnson, S., Linn, F. V., Peterson, L. R., & Gerding, D. N. (1990) · The Lancet · doi:10.1016/0140-6736(90)91605-a · Cited by 340
Thorens, J., Froehlich, F., Schwizer, W., Saraga, E., Bille, J., Gyr, K., Duroux, P., Nicolet, M., Pignatelli, B., Blum, A. L., et al. (1996) · Gut · doi:10.1136/gut.39.1.54 · Cited by 339
Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea
Cunningham, R., Dale, B., Undy, B., & Gaunt, N. (2003) · Journal of Hospital Infection · doi:10.1016/s0195-6701(03)00088-4 · Cited by 331
Clinical information for research; the use of general practice databases
Lawrenson, R., Williams, T., & Farmer, R. (1999) · Journal of Public Health · doi:10.1093/pubmed/21.3.299 · Cited by 255
Mylonaki, M., Langmead, L., Pantes, A., Johnson, F., & Rampton, D. S. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/01.meg.0000131040.38607.09 · Cited by 241
Epidemiology of Community-Acquired Clostridium difficile-Associated Diarrhea
Hirschhorn, L. R., Trnka, Y., Onderdonk, A., Lee, M.-L. T., & Platt, R. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.1.127 · Cited by 237
Barbut, F. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45804-0 · Cited by 211
Zedtwitz-Liebenstein, K., Wenisch, C., Patruta, S., Parschalk, B., Daxböck, F., & Graninger, W. (2002) · Critical Care Medicine · doi:10.1097/00003246-200205000-00026 · Cited by 206
Yoshida, N., Yoshikawa, T., Tanaka, Y., Fujita, N., Kassai, K., Naito, Y., & Kondo, M. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.014s1074.x · Cited by 190
A Prospective Nationwide Study of Clostridium difficile‐Associated Diarrhea in Sweden
Karlström, O. H., Fryklund, B. A., Tullus, K., BURMAN, L. G., & the Swedish C. difficile Study Group (1998) · Clinical Infectious Diseases · doi:10.1086/516277 · Cited by 177
McEllistrem, M. C., Carman, R. J., Gerding, D. N., Genheimer, C. W., & Zheng, L. (2005) · Clinical Infectious Diseases · doi:10.1086/427113 · Cited by 173
Geric, B., Rupnik, M., Gerding, D. N., Grabnar, M., & Johnson, S. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45610-0 · Cited by 164
Norén, T., Åkerlund, T., Bäck, E., Sjöberg, L., Persson, I., Alriksson, I., & Burman, L. G. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.8.3635-3643.2004 · Cited by 160
The Diagnostic Yield of Stool Pathogen Studies During Relapses of Inflammatory Bowel Disease
Meyer, A. M., Ramzan, N. N., Loftus, E. V., Heigh, R. I., & Leighton, J. A. (2004) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000139057.05297.d6 · Cited by 142
Infection Due to Clostridium difficile Among Elderly Residents of a Long-Term-Care Facility
Simor, A. E., Yake, S. L., & Tsimidis, K. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.4.672 · Cited by 127
Pathology of drug‐associated gastrointestinal disease
Price, A. B. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01980.x · Cited by 121
Albumin, Length of Stay, and Proton Pump Inhibitors
Al-Tureihi, F. I. J., Hassoun, A., Wolf‐Klein, G. P., & Isenberg, H. D. (2005) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2005.01.003 · Cited by 116
Occurrence and significance of gastric colonization during acid-inhibitory therapy
Williams, C. (2001) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2001.0191 · Cited by 111
Antibiotic‐associated diarrhoea and Clostridium difficile> in the community
Beaugerie, L., Flahault, A., Barbut, F., Atlan, P., Lalande, V., Cousin, P., Cadilhac, M., Petit, J., & FOR THE STUDY GROUP (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01531.x · Cited by 107
Spigaglia, P., & Mastrantonio, P. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45682-0 · Cited by 107
Wilson, K. H., Sheagren, J. N., & Freter, R. (1985) · The Journal of Infectious Diseases · doi:10.1093/infdis/151.2.355 · Cited by 105
Clostridium difficile infection and pseudomembranous colitis
Wilcox, M. H. (2003) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/s1521-6918(03)00017-9 · Cited by 98
Novel Approaches to Pharmacoepidemiology Study Design and Statistical Analysis
Suissa, S. (2000) · Pharmacoepidemiology · doi:10.1002/0470842555.ch44 · Cited by 97
Agastya, G., West, B. C., & Callahan, J. M. (2000) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970009016425 · Cited by 91
Gastric acid suppression does not promote clostridial diarrhoea in the elderly
Shah, S. (2000) · QJM · doi:10.1093/qjmed/93.3.175 · Cited by 88
National Clostridium difficile Standards Group: Report to the Department of Health
(2004) · Journal of Hospital Infection · doi:10.1016/j.jhin.2003.10.016 · Cited by 74
Weightman, N. C., & Lines, L. D. (2003) · Journal of Hospital Infection · doi:10.1016/j.jhin.2003.09.006 · Cited by 70
Vial, T., Goubier, C., Bergeret, A., Cabrera, F., Evreux, J. C., & Descotes, J. (1991) · Drug Safety · doi:10.2165/00002018-199106020-00002 · Cited by 66
Community-acquired Clostridium difficile infection
Kyne, L., Merry, C., O'Connell, B. C., Keane, C., & O’Neill, D. J. (1998) · Journal of Infection · doi:10.1016/s0163-4453(98)94207-4 · Cited by 61
Clostridium difficile in relation to enteric bacterial pathogens
Falsen, E., KAIJSER, B., Nehls, L., Nygren, B., & Svedhem, Å. (1980) · Journal of Clinical Microbiology · doi:10.1128/jcm.12.3.297-300.1980 · Cited by 56
Recurrent Pseudomembranous Colitis Unassociated With Prior Antibiotic Therapy
Moskovitz, M. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340050109025 · Cited by 38
Clostridium difficilein general practice and community health
Riley, T. V., Wymer, V., Bamford, V. W., & Bowman, R. A. (1986) · Journal of Hygiene · doi:10.1017/s0022172400062483 · Cited by 26
Gastrin-mediated effects of omeprazole on rat colon mucosa
Klingensmith, M. E., Neville, L. J., Delpire, E. J., Wolfe, M. M., & Soybel, D. I. (1999) · Surgery · doi:10.1016/s0039-6060(99)70165-0 · Cited by 16
Clostridium difficile—the next step in mandatory reporting
Barrett, S. P. (2004) · Journal of Hospital Infection · doi:10.1016/j.jhin.2003.12.001 · Cited by 4
Cited by
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., & Wilcox, M. H. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,942
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections
Surawicz, C. M., Brandt, L. J., Binion, D. G., Ananthakrishnan, A. N., Curry, S. R., Gilligan, P. H., McFarland, L. V., Mellow, M., & Zuckerbraun, B. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.4 · Cited by 1,645
Rosen, R., Vandenplas, Y., Singendonk, M., Cabana, M., DiLorenzo, C., Gottrand, F., Gupta, S., Langendam, M., Staiano, A., Thapar, N., et al. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001889 · Cited by 1,557
Clostridium difficile Infection
Leffler, D. A., & Lamont, J. T. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403772 · Cited by 1,450
Metadata
- Authors
- Dial, S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2005-12-21
- Volume
- 294
- Issue
- 23
- Pages
- 2989
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2148223907
- Cited by
- 958
- References
- 52
- FWCI
- 37.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.